Belmont Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $505K | Hold |
2,718
| – | – | 0.08% | 72 |
|
|
2025
Q1 | $569K | Sell |
2,718
-4,023
| -60% | -$843K | 0.1% | 59 |
|
|
2024
Q4 | $1.2M | Hold |
6,741
| – | – | 0.19% | 34 |
|
|
2024
Q3 | $1.33M | Buy |
6,741
+481
| +8% | +$95K | 0.22% | 36 |
|
|
2024
Q2 | $1.07M | Buy |
6,260
+612
| +11% | +$105K | 0.2% | 43 |
|
|
2024
Q1 | $1.03M | Buy |
5,648
+5,528
| +4,607% | +$1.01M | 0.28% | 38 |
|
|
2023
Q4 | $18.6K | Sell |
120
-548
| -82% | -$84.9K | 0.01% | 129 |
|
|
2023
Q3 | $99.6K | Buy |
668
+500
| +298% | +$74.5K | 0.05% | 91 |
|
|
2023
Q2 | $22.6K | Buy |
168
+120
| +250% | +$16.2K | 0.01% | 96 |
|
|
2023
Q1 | $7.65K | Hold |
48
| – | – | 0.01% | 112 |
|
|
2022
Q4 | $8K | Hold |
48
| – | – | 0.01% | 107 |
|
|
2022
Q3 | $6K | Buy |
+48
| New | +$6K | 0.01% | 102 |
|